Question:
Does Invokana (Canaglifozin) lower my blood sugar better than Glimepiride (Amaryl)?
Answer:
No
MedHead Confidence Score: 5
Amount Saved: $5,900 per year
MedHead Message:
Glimepiride (Amaryl) is now generic and costs $10 per month, while Invokana costs about $500 per month. There is no real difference in glucose lowering, but there is a difference in your cash lowering!
References:
1. Cefalu WT, Leiter LA, Yoon K-H, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet. 2013;382(9896):941-950. 2.
